Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study

Our objective was to develop version 1.0 of a novel framework for response evaluation criteria in prostate-specific membrane antigen (PSMA) PET/CT (RECIP) and a composite response classification that combines responses by prostate-specific antigen (PSA) measurements and by RECIP 1.0 (PSA + RECIP). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gafita, Andrei, Rauscher, Isabel, Weber, Manuel, Hadaschik, Boris, Wang, Hui, Armstrong, Wesley R., Tauber, Robert, Grogan, Tristan R., Czernin, Johannes, Rettig, Matthew B., Herrmann, Ken, Calais, Jeremie, Weber, Wolfgang A., Benz, Matthias R., Fendler, Wolfgang P., Eiber, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635677/
https://www.ncbi.nlm.nih.gov/pubmed/35422442
http://dx.doi.org/10.2967/jnumed.121.263072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635677/
https://www.ncbi.nlm.nih.gov/pubmed/35422442
http://dx.doi.org/10.2967/jnumed.121.263072

Ejemplares similares